Paper24670052
Importance of ABCC1 for cancer therapy and prognosis.
Kunická T and 1 other. Drug Metab Rev, 2014. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Importance of ABCC1 for cancer therapy and prognosis. Papers, record 24670052. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24670052
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ATP-Binding Cassette, Sub-Family C Proteins | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Drug Resistance, Multiple | |
| Drug Resistance, Neoplasm | |
| Humans | |
| Prognosis | |
| Xenobiotics |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42528604 | Drug-tolerant persister cells in lymphoid malignancies: from mechanisms to therapeutic opportunities. | Front Oncol | 2026 | https://conductscience.org/library/papers/42528604 | PubMed |
| 42353258 | Shared Transcriptomic Signatures and Network Interactions Between Lung Adenocarcinoma and Asthma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353258 | PubMed |
| 42178460 | miR-145 restoration overcomes oxaliplatin resistance via ABCC1 in colorectal cancer. | J Egypt Natl Canc Inst | 2026 | https://conductscience.org/library/papers/42178460 | PubMed |
| 41838341 | Extracellular levels of glutamate, glutamine, cystine, glutathione, and xanthine correlate with transporter expression in tamoxifen - resistant MCF-7 cells and poor overall survival in breast cancer patients. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/41838341 | PubMed |
| 41833022 | Thiourea Derivatives for the Potential Treatment of Lung Cancer via the Inhibition of EGFR and Efflux Pumps: Synthesis, In Silico, and In Vitro Studies. | Anticancer Agents Med Chem | 2026 | https://conductscience.org/library/papers/41833022 | PubMed |
| 41825961 | Immune Modulatory Oxysterols Produced from Cholesterol-Containing Lipid Nanoparticles Regulate Tumor Growth. | ACS Nano | 2026 | https://conductscience.org/library/papers/41825961 | PubMed |
| 41751467 | ABCC Gene Variants and Their Effects on Non-Response and Relapse in Pediatric Patients with Central Nervous System Tumors: A Cohort Study. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41751467 | PubMed |
| 41303640 | Targeting Multidrug Resistance in Cancer: Impact of Retinoids, Rexinoids, and Carotenoids on ABC Transporters. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41303640 | PubMed |
| 40575293 | LA-ICP-TOFMS Imaging Reveals Significant Influence of Cancer Cell Resistance on Oxaliplatin Compartmentalization in the Tumor Microenvironment. | JACS Au | 2025 | https://conductscience.org/library/papers/40575293 | PubMed |
| 39901896 | Circular RNAs in cancer. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/39901896 | PubMed |
| 39201483 | Precision Medicine in Childhood Cancer: The Influence of Genetic Polymorphisms on Vincristine-Induced Peripheral Neuropathy. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201483 | PubMed |
| 39108273 | Scinderin is a potential prognostic biomarker and correlated with immunological regulation: from pan-cancer analysis to liver hepatocellular carcinoma. | Front Immunol | 2024 | https://conductscience.org/library/papers/39108273 | PubMed |
| 38418897 | Development of a promising PPAR signaling pathway-related prognostic prediction model for hepatocellular carcinoma. | Sci Rep | 2024 | https://conductscience.org/library/papers/38418897 | PubMed |
| 37629489 | Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers? | Life (Basel) | 2023 | https://conductscience.org/library/papers/37629489 | PubMed |
| 37081981 | Investigating miR-9 as a mediator in laryngeal cancer health disparities. | Front Oncol | 2023 | https://conductscience.org/library/papers/37081981 | PubMed |
| 36845945 | Drug resistance of hepatoma cells induced by ATP‑binding cassette transporter G2 by reducing intracellular drug concentration. | Exp Ther Med | 2023 | https://conductscience.org/library/papers/36845945 | PubMed |
| 36106650 | Circular RNA circ-CD44 regulates chemotherapy resistance by targeting the miR-330-5p/ABCC1 axis in colorectal cancer cells. | Histol Histopathol | 2023 | https://conductscience.org/library/papers/36106650 | PubMed |
| 35090310 | ABCB1 limits the cytotoxic activity of TAK-243, an inhibitor of the ubiquitin-activating enzyme UBA1. | Front Biosci (Landmark Ed) | 2022 | https://conductscience.org/library/papers/35090310 | PubMed |
| 34330313 | Molecular features and vulnerabilities of recurrent chordomas. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34330313 | PubMed |
| 34088745 | Abcc1 and Ggt5 support lymphocyte guidance through export and catabolism of S-geranylgeranyl-l-glutathione. | Sci Immunol | 2021 | https://conductscience.org/library/papers/34088745 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCC1 | 4363 | PubTator's text mining | https://conductscience.org/library/genes/4363 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24670052
GET https://conductscience.org/api/papers/v1/24670052/cited_by?page=2